Filing Details
- Accession Number:
- 0001640334-21-000151
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-20 16:59:42
- Reporting Period:
- 2021-01-14
- Accepted Time:
- 2021-01-20 16:59:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 895464 | Yubo International Biotech Ltd | YBGJ | Electromedical & Electrotherapeutic Apparatus (3845) | 113074326 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1828246 | Wang Jun | Yubo International Biotech Limited Room 105, Building 5, Xishiku Avenue Xicheng District, Beijing F4 00000 | President And Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2021-01-14 | 39,943,800 | $0.00 | 39,943,800 | No | 4 | P | Indirect | Controlling Person of Entity |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | Controlling Person of Entity |
Footnotes
- The shares reported herein were acquired in connection with an exchange transaction by and among Platinum International Biotech Co., Ltd.("Platinum"), Yubo International Biotech (Beijing) Limited, the Reporting Person and certain other stockholders of Platinum. The Issuer issued the shares reported herein to the Reporting Person in exchange for the Reporting Person's equity interest in Platinum. No cash consideration was paid in connection with the exchange transaction.
- Reporting Person owns 100% of the equity interest in Flydragon International Limited, which is the record holder of the shares reported herein.
Billionaire Hedge Funds
